Establishing Effectiveness for Drugs Intended to Treat Male Hypogonadotropic Hypogonadism Attributed to Nonstructural Disorders Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 18, 2018
December 1, 2018
45fa3246-6fd0-427b-9f31-dfee7ddb4a0a
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment
Guidance DocumentMay 22, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.